Primary Human Retinal Pericyte Cells

Cat.No.: CSC-C4360X

Species: Human

Source: Retina; Eye

Cell Type: Pericyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4360X
Description
Primary Human Retinal Pericyte Cells (HRPEpiC) are isolated from human retina. HRPEpiC are cryopreserved at passage one and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HRPEpiC are characterized by immunofluorescent method with antibodies to cytokeratin-18, cytokeratin-19 and fibronectin. HRPEpiC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HRPEpiC are guaranteed to further expand for 15 population doublings in the condition provided by Creative Bioarray.
Species
Human
Source
Retina; Eye
Cell Type
Pericyte
Disease
Normal
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Primary Human Retinal Pericyte Cells (HRPCs) are mural cells that cover the retinal capillaries. They are involved in the regulation of capillary tone, angiogenesis, blood-retinal barrier (BRB) function and maintenance of vascular stability. Isolated from human retinal microvasculature, these cells exhibit a characteristic stellate morphology with multiple cytoplasmic processes that make direct contact with endothelial cells. HRPCs express PDGFR-β, NG2 proteoglycan and α-SMA markers while they do not show any endothelial (CD31) or glial (GFAP) markers.

Functionally, HRPCs regulate capillary tone through contractile properties, modulate endothelial cell proliferation via PDGF-B/PDGFR-β signaling, and contribute to BRB integrity. The cell dysfunction and pericyte loss leads to diabetic retinopathy (DR), which is induced by chronic hyperglycemia and causes microaneurysms and vascular leakage. HRPCs also play a role in inflammatory responses in the retina by producing cytokines, such as IL-6 and MCP-1. Primary HRPCs have been used in studies related to microvascular disorders, drug development for DR, as well as in assays related to vascular stability. They are often co-cultured with endothelial cells to reconstruct the retinal vasculature in vitro.

Retinal vasculature in diabetic retinopathy.

Fig. 1. Retinal vasculature in diabetic retinopathy (Santos G, Prazeres P, et al., 2018).

Human Retinal Microvascular Endothelial Cells and Human Retinal Pericyte Cells were Viable in Sustained Hyperglycaemia and Hypoxia

Diabetic retinopathy (DR) is often detected late, leading to vision loss. Eyre et al. uses a human primary co-culture model of retinal microvascular endothelial cells and pericytes to investigate cellular changes in DR. Cells were cultured for up to 21 days under normoxic or hypoxic conditions and physiological or high glucose levels.

hREC and hRP were exposed to 5% oxygen (hypoxic stimulus) to induce a hypoxic response. Ang-2 was activated in hREC and SOD-2 was activated in hRP. In the hypoxic response, a 2% oxygen condition was used in place of 20% oxygen in both normoglycemic and high glucose due to the negligible differences observed. hRP cultured in 20% oxygen and high glucose conditions had higher metabolic activity on day 21 compared to cells cultured in high glucose alone (Fig. 1A). In a hypoxic state (2% oxygen), hRP cultured in high glucose had higher metabolic activity than hRP cultured in normoglycemic conditions (Fig. 1B). hREC cultured in 20% oxygen and high glucose had lower metabolic activity compared to cells cultured in normoglycemic conditions (Fig. 1C). In 2% oxygen, no differences in hREC metabolic activity or cell number were observed between normoglycemic and very high glucose conditions (Fig. 1D). No significant differences were observed between normoglycemic and osmotic control conditions by day 21.

Glucose and oxygen analysis for long-term culture of hRP and hREC hRP (A,B) and hREC.

Fig. 1. Glucose and oxygen analysis for long-term culture of hRP and hREC hRP (A,B) and hREC (C,D) (Eyre J J, Williams R L, et al., 2020).

hASC Differentiation into Pericyte-Like Cells

Adipose-derived mesenchymal stem cells (ASCs) can differentiate into various cell types. Pericytes are crucial for stabilizing blood vessels, and their loss, as seen in diabetic retinopathy, leads to blood-retina barrier (BRB) breakdown. Mannino et al. aim to explore in vitro strategies to differentiate human ASCs into pericyte-like cells to restore BRB integrity.

To identify the capacity of hASCs to differentiate into pericyte-like cells, we determined the expression of cell lineage markers α-SMA (Fig. 2) and NG2 (Fig. 3) by immunopositivity. Immunostaining was performed at 1, 3, and 6 days in culture in four hASC groups (hASCs, TGF-hASCs, noPGS-hASCs, and PM-hASCs) and native pericytes (hRPCs). In the hRPCs and all hASC groups, only basal expression of α-SMA could be detected at day 1 (Fig. 2, left column). At day 3 and day 6, the expression of α-SMA was higher in the control hASCs, TGF-hASCs and noPGS-hASCs and appeared filamentous (Fig. 2, middle and right columns). On the other hand, the expression of α-SMA did not change in hRPCs and PM-hASCs during the whole time course (Fig. 2, last two rows). NG2 expression was higher in hRPCs at all time points (Fig. 3, last row) and in PM-hASCs only, among the hASCs groups (Fig. 3, second-last row), showing weak staining in the other groups and time points.

α-Smooth muscle actin immunoreactivity (red fluorescence) evaluated after one day (left column, 1 d), three days (middle column, 3 d) and six days (right column, 6 d) of cell growth.

Fig. 2. α-Smooth muscle actin immunoreactivity (red fluorescence) evaluated after one day (left column, 1 d), three days (middle column, 3 d) and six days (right column, 6 d) of cell growth (Mannino G, Gennuso F, et al., 2020).

Neural/glial antigen 2 immunoreactivity (green fluorescence) evaluated after one day (left column, 1 d), three days (middle column, 3 d) and six days (right column, 6 d) of cell growth.

Fig. 3. Neural/glial antigen 2 immunoreactivity (green fluorescence) evaluated after one day (left column, 1 d), three days (middle column, 3 d) and six days (right column, 6 d) of cell growth (Mannino G, Gennuso F, et al., 2020).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products